A Pictorial Review of Uncommon Non-oncologic Clinical Cardiovascular Applications of FDG PET-CT

J Lam, S Squier, J Accurso, M Jain, A Sharma - 2017 - Soc Nuclear Med
1004 Objectives: 1. Review the current diagnostic role of FDG PET/CT in the diagnosis and
management of non-oncologic cardiovascular disease. 2. Further describe its potential utility …

[BOOK][B] FDG-PET/CT and PET/MR in Cardiovascular Diseases

M Pelletier-Galarneau, P Martineau - 2022 - books.google.com
This book is a clinically oriented, up-to-date, and in-depth review of the various applications
of FDG-PET/CT and PET/MR in cardiovascular diseases with emphasis on the current …

The Role of PET with [18-F] Fluorodeoxyglucose in the Diagnosis and Management of Thoracic Vascular Disease

YD Yu, DA Torigian, NN Mehta - PET clinics, 2011 - pet.theclinics.com
The role of positron emission tomography (PET) in thoracic vascular diseases has grown
substantially since [18-F] Fluorodeoxyglucose uptake was first reported in large vessels …

18F-FDG PET/CT Imaging: Normal Variants, Pitfalls and Artefacts

K Agrawal, G Gnanasegaran, E Skoura… - PET/CT Imaging: Basics …, 2022 - Springer
In recent years, positron emission tomography (PET)/computed tomography (CT) has gained
widespread clinical acceptance in oncology. It is being used extensively in the diagnosis …

Vascular findings on FDG PET/CT

S Liddy, A Mallia, CD Collins, RP Killeen… - The British Journal of …, 2020 - academic.oup.com
Since its introduction into clinical practice, 2-deoxy-2-[18F] flu-D-glucose (FDG) positron
emission tomography/computed tomography (PET/CT) has become firmly established in the …

Normal variants in [18F]-fluorodeoxyglucose PET imaging

G El-Haddad, A Alavi, A Mavi, G Bural… - Radiologic …, 2004 - radiologic.theclinics.com
Since the introduction of [18F]-fluorodeoxyglucose PET (FDG-PET) in 1976, it has evolved
from a research imaging modality to become a powerful tool improving the management of …

Incidental cardiac findings on routine oncology FDG-PET/CT scans: Normal variants, benign and pathologic conditions with histopathologic correlation

C Smith, M Baum, T Akhurst - 2007 - Soc Nuclear Med
1001 Learning Objectives: 1. Highlight the normal variations in FDG uptake in the heart. 2.
Describe benign entities that can cause increased FDG activity in the heart. 3. Describe …

A pictorial essay demonstrating F 18 FDG PET-CT identification of unsuspected cardiovascular masses

D Rajderkar, A Bhat, K Fischer, G Agrawal - 2011 - Soc Nuclear Med
1001 Learning Objectives FDG-PET-CT is routinely performed as part of the imaging work
up for many primary malignancies. Incidental finding of cardiovascular involvement can …

[HTML][HTML] Cardiac and pericardial 18F-FDG uptake on oncologic PET/CT: comparison with echocardiographic findings

JE Yi, HJ Yoon, HJ Youn - Journal of Cardiovascular Imaging, 2018 - ncbi.nlm.nih.gov
BACKGROUND Interpretation of cardiac uptake on 18-fluorodeoxyglucose positron
emission tomography/computed tomography (18 F-FDG PET/CT) is often confounded by …

Atypical and equivocal presentations of lung cancer on CT imaging–a pictorial essay

IS Sachdev, SS Atwal, RH Briggs - Clinical Radiology, 2020 - clinicalradiologyonline.net
Outline of submission: 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) is the most common
radiopharmaceutical used in positron emission tomography-computed tomography (PET …